Welcome to our dedicated page for PRO DEX SEC filings (Ticker: PDEX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on PRO DEX's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into PRO DEX's regulatory disclosures and financial reporting.
PRO DEX INC (PDEX) entered into a Third Amendment to its Standard Industrial/Commercial Multi-Tenant Lease – Net with Irvine Business Properties, effective August 18, 2026. The lease covers approximately 28,180 square feet at 2361 McGaw Avenue in Irvine, California, which includes the company’s executive offices and manufacturing facility.
The amendment extends the lease term to September 30, 2030 and, beginning October 1, 2027, provides for 3.5% annual base rent increases. Base rent will be $49,281.75 per month from October 1, 2027 through September 30, 2028 and will increase by 3.5%, or $1,724.86 per month, on October 1, 2028 and an additional 3.5% per month, or $1,785.23 per month, on October 1, 2029. Other lease terms remain unchanged.
PRO DEX INC (PDEX) reports that Chief Executive Officer and director Richard Lee Van Kirk Jr sold 765 shares of common stock on September 11, 2026 in two open-market or private transactions. The sales, executed under a Rule 10b5-1 trading plan adopted on May 28, 2026, occurred at weighted average prices of $58.94 for 290 shares (with individual prices ranging from $58.36 to $59.35) and $59.62 for 475 shares (with individual prices ranging from $59.39 to $59.91).
PRO DEX INC (PDEX) reported that its Chief Executive Officer and director, Richard Lee Van Kirk Jr, sold a total of 19,235 shares of common stock on September 9, 2026 in a series of open-market transactions under a Rule 10b5-1 trading plan adopted on May 28, 2026, at weighted average prices generally in the high-$50s to mid-$60s per share, each calculated from multiple trades within disclosed price ranges.
PRO DEX INC (PDEX) reported that Chief Financial Officer Alisha Charlton sold a total of 2,300 shares of common stock on September 9, 2026 in open-market transactions. The sales consisted of 1,500 shares at a weighted average price of $61.05 and 800 shares at a weighted average price of $61.76. The 1,500-share sale occurred in multiple trades between $60.59 and $61.41, and the 800-share sale in trades between $61.674 and $61.92. No Rule 10b5-1 trading plan is reported for these transactions.
PRO DEX INC (PDEX) has a planned resale under Rule 144 by stockholder Richard Van Kirk Jr. The notice covers the proposed sale of 20,000 shares of common stock, with an indicated aggregate market value of $1,294,000.00 and reference to 3,203,334 shares of common stock, as of a stated context.
The shares to be sold were acquired through a stock option exercise on September 9, 2020, from the issuer. The proposed Rule 144 sale is dated September 9, 2026, and the shares are held through The Charles Schwab Corporation in an account associated with the filer.
PRO DEX INC (PDEX) received a Rule 144 notice from its Chief Financial Officer, Alisha Charlton, covering a proposed sale of 2,300 shares of common stock through Charles Schwab.
The notice reports an aggregate market value of $168,843 for these shares, based on the NASDAQ Capital Market closing price on September 4, 2026, with an approximate sale date of September 9, 2026 and 3,203,334 shares outstanding.
PRO DEX INC (PDEX) reported strong results for the fourth quarter and fiscal year ended June 30, 2026. Q4 net sales rose to $20.4 million, up 17% from $17.5 million, driven primarily by higher volumes of its largest customer’s next generation orthopedic handpiece. Q4 gross profit more than doubled to $7.1 million, lifting gross margin to 35% from 20%, while operating income increased to $3.5 million and net income to $2.9 million, or $0.87 per diluted share.
For fiscal 2026, net sales grew 16% to $77.5 million, gross profit increased 25% to $24.3 million, and gross margin improved to 31% from 29%. Operating income rose 22% to $13.0 million, and net income reached $13.7 million, or $4.12 per diluted share, aided by $5.7 million of gains on marketable equity investments. The acquisition of Advanced Precision Machining, LLC contributed additional revenue and higher margins but also added consulting and operating costs. Cash and cash equivalents increased to $8.2 million, while total notes payable rose to about $17.5 million.
Pro-Dex, Inc. (PDEX) reported strong growth for the year ended June 30, 2026, with net sales of $77.5 million, up 16% from 2025, and net income of $13.7 million, up from $9.0 million. Gross margin improved to 31%, and operating income rose to $13.0 million (17% of sales).
Growth was driven by a 30% increase in medical device revenue to $62.1 million, particularly orthopedic products for its largest customer following a next‑generation handpiece launch, while repair revenue declined 33% to $12.5 million as that customer transitioned away from legacy devices. Pro-Dex acquired Advanced Precision Machining, LLC (APM) in February 2026, adding aerospace and defense machining capabilities and contributing to a 76% increase in industrial and scientific sales. Other income benefited from realized gains on the Monogram investment, and the company generated $7.2 million of operating cash flow, ending the year with $8.2 million in cash and $40.3 million of working capital. Backlog was $32.9 million, down from $50.4 million, with most expected to ship in fiscal 2027. The company repurchased 79,898 shares for $3.4 million and had 3,203,334 shares outstanding as of September 2, 2026.
PRO DEX INC (PDEX) reported a compensation decision for senior management. On August 26, 2026, the Compensation Committee approved a $60,000 discretionary cash bonus for Chief Financial Officer Alisha K. Charlton and a $140,000 discretionary cash bonus for Chief Executive Officer Richard L. Van Kirk.
The company states that Mr. Van Kirk’s bonus was based on sales growth and fiscal 2026 financial performance exceeding plan. Both bonuses will be paid in cash in the next bi-weekly pay period, with a pay date of September 3, 2026. No other material corporate actions are described.
Pro Dex Inc director Angelita Rebamontan acquired 19 shares of common stock on July 23, 2026 at $33.25 per share through an Employee Stock Purchase Plan in transactions exempt under Rule 16b-3(c) and Rule 16b-3(d). After this acquisition, she directly holds 18,798 shares.